Navigation Links
Dow AgroSciences Receives Approval for New Technology to Control Cotton Pests in Brazil
Date:3/19/2009

Technology incorporates naturally occurring soil micro-organism proteins to protect cotton plantations

INDIANAPOLIS and SAO PAULO, March 19 /PRNewswire/ -- Dow AgroSciences LLC, a wholly owned subsidiary of The Dow Chemical Company (NYSE: DOW), today announced that it has received regulatory approval from the Brazilian National Technical Commission of Biosafety (CTNBio), for its WideStrike(TM) Insect Protection technology in cotton in Brazil. WideStrike, currently marketed in the United States, provides season-long, whole-plant protection from insect feeding cotton pests.

The WideStrike technology uses two insect resistant traits that effectively control important cotton pests especially the Spodoptera frugiperda, Heliothis virescens, Pectinophora gossypiella, and the Alabama argillacea pests. Studies conducted by Dow AgroSciences and analyzed by CTNBio show that WideStrike does not create unreasonable risk to humans or the environment.

"The cultivation of cotton has gained strength in recent years in Brazil for its fiber," said Rolando Alegria, Seeds and Biotechnology director, Dow AgroSciences in Brazil. "Additionally, WideStrike contributes to a more sustainable agriculture because it controls the most harmful pests to cotton plantations. Dow AgroSciences will now be able to provide access to its company's technologies - which are among the most advanced of the world - to a larger number of growers."

Before becoming available in the Brazilian market, this technology has gone through rigorous testing in several regions of the country, and also has been tested in laboratories.

Cottonseed containing this technology has been planted since 2004 in the United States where the oil and meal produced from WideStrike cottonseed has been approved for use in human food and animal feed. These products have also been approved for use in human food and animal feed in Canada and in Japan, as well as for in human food in Mexico, South Korea, and Australia.

In December 2008, CTNBio granted its approval to Dow AgroSciences for HERCULEX(R) I Insect Protection technology that provides protection against the main corn pest in Brazil, the sugar cane borer and fall armyworm (Spodoptera frugiperda). The commercialization of the HERCULEX I hybrid corn seeds, which also produces a Bt protein to protect the plant, has already been approved by the Brazilian Ministry of Agriculture.

About Dow AgroSciences

Dow AgroSciences LLC, based in Indianapolis, Indiana, USA, is a top-tier agricultural company that combines the power of science and technology with the "Human Element" to constantly improve what is essential to human progress. Dow AgroSciences provides innovative technologies for crop protection, pest and vegetation management, seeds, traits, and agricultural biotechnology to serve the world's growing population. Global sales for Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, are $4.5 billion. Learn more at www.dowagro.com.

(TM)(R)HERCULEX and WideStrike are registered trademarks of Dow AgroSciences LLC


'/>"/>
SOURCE Dow AgroSciences
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Dow AgroSciences, China National Rice Research Institute Announce Collaboration on Rice Research
2. Dow AgroSciences Delivering Beyond Expectations
3. Dow AgroSciences Receives Approval for Cultivation of HERCULEX(R) I Corn in Brazil
4. Dow AgroSciences Announces Early Exercise of Option for Commercial License With Sangamo BioSciences for Plants
5. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestones in Plant Agriculture Collaboration
6. Dow AgroSciences, Martek Biosciences Form Alliance to Bring Omega-3 Fatty Acids to Food Industry
7. Dow AgroSciences, Sangamo BioSciences Announce the Achievement of Key Milestone in Plant Agriculture Collaboration
8. Dow AgroSciences Success Presented to Wall Street
9. Dow AgroSciences and Exelixis Plant Sciences Announce Major Research Collaboration, Asset Purchase to Advance Gene Discovery and Validation
10. Intradigm Receives Notice of Allowance for Key RNA Interference (RNAi) Patent Covering Potent siRNA Sequence
11. Helix BioPharma Receives Approval to Initiate Phase II Pharmacokinetic Clinical Study of Topical Interferon Alpha-2b in Patients with Low-Grade Cervical Lesions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/1/2017)...  Elizabeth Young and Joshua Rosenthal , PhD, ... University,s Health Workforce Speaker series. http://bit.ly/2lA6C8B ... be speaking on March 9, 2017 at the Milken ... DC at 12:00pm. The George ... speakers to examine new workforce configurations, their outcomes and ...
(Date:2/28/2017)... ... February 28, 2017 , ... Surface Plasmon Resonance (SPR) is ... optical phenomenon that is sensitive to changes in the dielectric properties of the medium ... changes in refractive index occurring up to 300 nm above the metal surface (Au) ...
(Date:2/28/2017)... ... February 28, 2017 , ... ... MIDI, Inc. (Newark, DE) have formed a strategic partnership to develop and ... and renewable energy laboratories. These automated testing solutions will save analysis time ...
(Date:2/28/2017)... NEW YORK , Feb. 28, 2017 /PRNewswire/ ... company, announced today the formation of the Phosphorus ... and science experts chosen to advise the company ... company,s large-scale, multi-site research initiatives. Please visit ... team and initiatives. "We,ve gathered some ...
Breaking Biology Technology:
(Date:2/8/2017)... 8, 2017 About Voice Recognition Biometrics Voice ... it against a stored voiceprint template. Acoustic features ... and tone are compared to distinguish between individual ... as most PCs already have a microphone and ... recognition biometrics are most likely to be deployed ...
(Date:2/7/2017)...   MedNet Solutions , an innovative SaaS-based eClinical ... research, is pleased to announce that the latest release ... flexible and award winning eClinical solution, is now available ... is a proven Software-as-a-Service (SaaS) clinical research technology platform ... also delivers an entire suite of eClinical tools to ...
(Date:2/3/2017)... 3, 2017 A new independent identity strategy ... LLP (IdSP) . Designed to fill a critical niche ... market, founding partners Mark Crego and ... just in identity expertise that span federal governments, the ... The Crego-Kephart combined expertise has a common theme born ...
Breaking Biology News(10 mins):